US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has announced the launch of the Invenia Automated Breast Ultrasound (ABUS) Premium. This advanced 3D ultrasound system integrates artificial intelligence (AI) and innovative features to enable faster, reproducible supplemental screening and streamline exam readings for patients with dense breasts.
Addressing Challenges in Dense Breast Screening
Women with dense breasts often face poorer treatment outcomes, as malignant tumors are typically detected at more advanced and severe stages. The Invenia ABUS Premium, equipped with AI technology, has the potential to optimize clinicians’ screening capabilities. It helps healthcare professionals detect small and early-stage cancers more intelligently and efficiently, addressing a critical unmet need in breast cancer diagnosis.
AI-Enhanced Clinical Workflow
Clinicians can leverage the Invenia ABUS Viewer, which comes with AI assistants, to quickly read images both in-clinic and remotely. This feature not only speeds up the diagnostic process but also enhances accuracy, ensuring that patients receive timely and appropriate care. The system’s innovative design and AI integration represent a significant step forward in the management of breast cancer screening for women with dense breasts.-Fineline Info & Tech
Leave a Reply